Gilead Sciences (GILD) Ending Cash Balance (2009 - 2026)
Gilead Sciences (GILD) reported Ending Cash Balance of $6.44 billion for Q3 2026, down 12.2% from $7.33 billion a year earlier but up 102.5% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, Gilead Sciences posted Ending Cash Balance of $7.56 billion, down 24.3% from FY2024.
- Ending Cash Balance has a five-year compound annual growth rate of 4.8% (FY2020 to FY2025).
- By year, Ending Cash Balance came in at $9.99 billion in FY2024 (+64.2%), $6.09 billion in FY2023 (+12.4%), $5.41 billion in FY2022 (+1.4%) and $5.34 billion in FY2021 (-11.0%).
- Five-year quarterly Ending Cash Balance spans a low of $2.77 billion in Q2 2024 and a high of $9.99 billion in Q4 2024.
- Year over year, Ending Cash Balance has now declined in each of the last four quarters, with growth averaging 23.1% over the last eight quarters.
- The high point for year-over-year Ending Cash Balance in five years was Q2 2025 (growth of 85.6%); the low point was Q2 2024 (a decline of 51.4%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $3.18 billion (Q2 2026), $7.63 billion (Q1 2026) and $7.56 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,333.71 Bn | 1,307.33 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.21 Bn | 585.07 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.27 Bn | 489.32 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 370.99 Bn | 325.42 Bn | 12.21 Bn | 6.89 Bn |
| 5 | Novartis Ag | 314.75 Bn | 288.32 Bn | - | - |
| 6 | Astrazeneca | 293.18 Bn | 267.16 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 258.67 Bn | 214.07 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 216.53 Bn | 191.55 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 175.50 Bn | 123.16 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Vertex Pharmaceuticals | 139.19 Bn | 111.18 Bn | 2.91 Bn | 4.99 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.44 Bn |
| Jun 30, 2026 | 3.18 Bn |
| Mar 31, 2026 | 7.63 Bn |
| Dec 31, 2025 | 7.56 Bn |
| Sep 30, 2025 | 7.33 Bn |
| Jun 30, 2025 | 5.14 Bn |
| Mar 31, 2025 | 7.93 Bn |
| Dec 31, 2024 | 9.99 Bn |
| Sep 30, 2024 | 5.04 Bn |
| Jun 30, 2024 | 2.77 Bn |
| Mar 31, 2024 | 4.72 Bn |
| Dec 31, 2023 | 6.09 Bn |
| Sep 30, 2023 | 5.71 Bn |
| Jun 30, 2023 | 5.70 Bn |
| Mar 31, 2023 | 4.94 Bn |
| Dec 31, 2022 | 5.41 Bn |
| Sep 30, 2022 | 4.70 Bn |
| Jun 30, 2022 | 4.74 Bn |
| Mar 31, 2022 | 4.30 Bn |
| Dec 31, 2021 | 5.34 Bn |
API Access
Gilead Sciences Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();